In order to explore the possibility of HLA-mismatched hematopoietic stem cell transplantation from family donors beyond haploidentical relatives, the authors conducted a prospective Phase I/II study of 2-HLA-haplotype-mismatched hematopoietic stem cell transplantation (HSCT).
[Bone Marrow Transplantation]
1254621
{1254621:U7VMZV2E}
apa
50
1
151004
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-2f818a3ee17af7a8be66cc354941ae19%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22U7VMZV2E%22%2C%22library%22%3A%7B%22id%22%3A1254621%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ikegame%20et%20al.%22%2C%22parsedDate%22%3A%222020-06-20%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EIkegame%2C%20K.%2C%20Kaida%2C%20K.%2C%20Fukunaga%2C%20K.%2C%20Osugi%2C%20Y.%2C%20Yoshihara%2C%20K.%2C%20Yoshihara%2C%20S.%2C%20Ishii%2C%20S.%2C%20Fujino%2C%20S.%2C%20Yamashita%2C%20T.%2C%20Mayumi%2C%20A.%2C%20Maruyama%2C%20S.%2C%20Teramoto%2C%20M.%2C%20Inoue%2C%20T.%2C%20Okada%2C%20M.%2C%20Tamaki%2C%20H.%2C%20Ogawa%2C%20H.%2C%20%26amp%3B%20Fujimori%2C%20Y.%20%282020%29.%20Allogeneic%20hematopoietic%20stem%20cell%20transplantation%20from%20a%202-HLA-haplotype-mismatched%20family%20donor%20for%20posttransplant%20relapse%3A%20a%20prospective%20phase%20I%5C%2FII%20study.%20%3Ci%3EBone%20Marrow%20Transplantation%3C%5C%2Fi%3E%2C%201%26%23x2013%3B14.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41409-020-0980-8%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41409-020-0980-8%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1254621%26amp%3Bitem_key%3DU7VMZV2E%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Allogeneic%20hematopoietic%20stem%20cell%20transplantation%20from%20a%202-HLA-haplotype-mismatched%20family%20donor%20for%20posttransplant%20relapse%3A%20a%20prospective%20phase%20I%5C%2FII%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kazuhiro%22%2C%22lastName%22%3A%22Ikegame%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katsuji%22%2C%22lastName%22%3A%22Kaida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keiko%22%2C%22lastName%22%3A%22Fukunaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuko%22%2C%22lastName%22%3A%22Osugi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyoko%22%2C%22lastName%22%3A%22Yoshihara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satoshi%22%2C%22lastName%22%3A%22Yoshihara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shinichi%22%2C%22lastName%22%3A%22Ishii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satoshi%22%2C%22lastName%22%3A%22Fujino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takaya%22%2C%22lastName%22%3A%22Yamashita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azusa%22%2C%22lastName%22%3A%22Mayumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satoshi%22%2C%22lastName%22%3A%22Maruyama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masahiro%22%2C%22lastName%22%3A%22Teramoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takayuki%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masaya%22%2C%22lastName%22%3A%22Okada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroya%22%2C%22lastName%22%3A%22Tamaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroyasu%22%2C%22lastName%22%3A%22Ogawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yosihiro%22%2C%22lastName%22%3A%22Fujimori%22%7D%5D%2C%22abstractNote%22%3A%22HLA%20haploidentical%20hematopoietic%20stem%20cell%20transplantation%20%28HSCT%29%2C%20i.e.%2C%20HSCT%20from%20a%201-HLA-haplotype-mismatched%20family%20donor%2C%20has%20been%20successfully%20performed%20even%20as%20a%20second%20transplantation%20for%20posttransplant%20relapse.%20Is%20the%20haploidentical%20the%20limit%20of%20HLA%20mismatches%20in%20HSCT%3F%20In%20order%20to%20explore%20the%20possibility%20of%20HLA-mismatched%20HSCT%20from%20family%20donors%20beyond%20haploidentical%20relatives%2C%20we%20conducted%20a%20prospective%20phase%20I%5C%2FII%20study%20of%202-HLA-haplotype-mismatched%20HSCT%20%282-haplo-mismatch%20HSCT%29.%20We%20enrolled%2030%20patients%20with%20posttransplant%20relapse%20%28acute%20myeloid%20leukemia%3A%2018%2C%20acute%20lymphoblastic%20leukemia%3A%2011%2C%20non-Hodgkin%20lymphoma%3A%201%29.%202-haplo-mismatch%20HSCT%20was%20performed%20as%20the%20second%20to%20sixth%20transplantations.%20The%20donors%20were%20siblings%20%28n%5Cu2009%3D%5Cu200912%29%2C%20cousins%20%28n%5Cu2009%3D%5Cu200916%29%2C%20and%20second%20cousins%20%28n%5Cu2009%3D%5Cu20092%29.%20The%20conditioning%20regimen%20consisted%20of%20fludarabine%2C%20cytarabine%2C%20melphalan%2C%20low-dose%20anti-thymocyte%20globulin%2C%20and%203%5Cu2009Gy%20of%20total%20body%20irradiation.%20Graft-versus-host%20disease%20%28GVHD%29%20prophylaxis%20consisted%20of%20tacrolimus%2C%20methylprednisolone%2C%20and%20mycophenolate%20mofetil.%20All%20patients%20achieved%20neutrophil%20engraftment%2C%20except%20for%20a%20case%20of%20early%20death.%20The%20cumulative%20incidences%20of%20grades%20II%5Cu2013IV%20and%20III%5Cu2013IV%20acute%20GVHD%20were%2036.7%25%20and%2016.7%25%2C%20respectively.%20The%20overall%20survival%20at%201%20year%2C%20relapse%2C%20and%20non-relapse%20mortality%20rates%20was%2030.1%25%2C%2038.9%25%2C%20and%2044.3%25%2C%20respectively.%20Considering%20the%20poor%20prognosis%20of%20posttransplant%20relapse%2C%202-haplo-mismatch%20HSCT%20can%20be%20an%20alternative%20option%20in%20a%20second%20or%20third%20transplantation.%22%2C%22date%22%3A%222020-06-20%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41409-020-0980-8%22%2C%22ISSN%22%3A%221476-5365%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41409-020-0980-8%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222020-06-22T17%3A06%3A53Z%22%7D%7D%5D%7D
Ikegame, K., Kaida, K., Fukunaga, K., Osugi, Y., Yoshihara, K., Yoshihara, S., Ishii, S., Fujino, S., Yamashita, T., Mayumi, A., Maruyama, S., Teramoto, M., Inoue, T., Okada, M., Tamaki, H., Ogawa, H., & Fujimori, Y. (2020). Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospective phase I/II study. Bone Marrow Transplantation, 1–14. https://doi.org/10.1038/s41409-020-0980-8 Cite
